Page 41 - Sohini Das

Breather for consumers as drug prices likely to remain same this year

In previous two years, hikes were in the range of 10-12%

Battle shifts to new class of drugs in diabetes treatment in India

Glenmark Pharmaceuticals launched a biosimilar version of liraglutide earlier this month, after getting the nod from the Drugs Controller General of India (DCGI)

Cipla board rejig: Samina Hamied to step down from executive role

Balram Bhargava appointed as independent director on board

Indian firms corner more of growing pharma market as MNCs go niche

Indian drug firms are focussing on expanding their salesforce and distri­bution, while getting into trade generics to garner volumes

Bajaj Auto Q3 net profit up 38% at Rs 2,032 cr on good domestic biz

No.3 in electric 2-wheeler market riding on Chetak, clocks 10K units-pm volumes

Aster DM shareholders approve separation of firm's India, GCC businesses

Aster DM earlier announced plans to separate its India and Gulf businesses in a deal valued at $1 billion

Result preview: Auto Inc may ride on strong revenue growth in Dec qtr

Analysts say margins would also be helped by benign commodity prices

Serum Institute joins CEPI network to make vaccines for disease outbreaks

$30 mn invesment will expand company's ability to swiftly supply investigational vaccines for the Global South

Q3 result preview: US, India to aid revenue growth for Pharma Inc

In the healthcare segment, hospitals are expected to post revenue growth of 13 percent during the coverage, while the net profit growth would be around 37 percent, ICICI Securities said in a note

Cipla's net profit jumps 32% to Rs 1,055.9 crore in third quarter

Cipla advanced its board meeting to January 22 to approve its results for the quarter and nine months ended December 31, 2023, to avoid confusion following an alleged social media leak

Average selling price of passenger vehicles in India up by 50% in 5 years

ASP has gone up from Rs 7.65 lakh in 2018-19 to Rs 11.5 lakh in 2023-24, according to the industry. Premiumisation, changing regulatory norms and SUV craze lead to price hikes

Data lakes, AI-machine learning tools help auto OEMs in production

Automakers are using these models to make informed, strategic, tactical decisions across domains

Hyundai buys GM's Talegaon plant, will invest Rs 6,000 cr in Maharashtra

Plant will be 'catalyst' in achieving Hyundai India's target of achieving one million annual production capacity, says company

Holidays, live telecast of Ram Mandir event: Stage set for a Ramayana redo

The excitement around the Ram Mandir consecration is building up and it's spreading across the country - from housing societies, temples to schools

Sun Pharma to acquire remaining stake in Israeli firm Taro for Rs 2,892 cr

Merger would pave the way for Sun to consolidate its position in the US market, say analysts

Tata Passenger Electric Mobility nears break-even: MD Shailesh Chandra

He talks about how the company is focusing on going fully electric and moving away from petrol and diesel powertrains

Imports of medical devices rise 21% till October to Rs 61,262.84 cr

Imports from the US grew by 33 per cent, followed by Germany (27 per cent) and the Netherlands (20 per cent). The imports from China grew by 11 per cent the data shows

ICMR invites suggestions for revising national essential diagnostics list

It is unclear whether the finalisation of the NEDL will lead to price capping of diagnostic tests in line with drugs

Fortis Healthcare plans acquisitions, may opt for neutral brand name

We have taken a calculative view that at least for SRL, we have moved to the Agilus brand, and we have successfully completed that last year, said CFO of Fortis Healthcare

Bombay High Court junks pleas challenging closure of Talegaon plant

The High Court upheld the decision of the Industrial Tribunal allowing GMI to close the plant after noting accumulated losses of Rs 9,656.87 crore as of 2021-22